Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR)

BACKGROUND: Patients with early breast cancer (EBC) achieving pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT) have a favorable prognosis. Breast surgery might be avoided in patients in whom the presence of residual tumor can be ruled out with high confidence. Here, we invest...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast Cancer Res
Autori principali: Gampenrieder, Simon Peter, Peer, Andreas, Weismann, Christian, Meissnitzer, Matthias, Rinnerthaler, Gabriel, Webhofer, Johanna, Westphal, Theresa, Riedmann, Marina, Meissnitzer, Thomas, Egger, Heike, Klaassen Federspiel, Frederike, Reitsamer, Roland, Hauser-Kronberger, Cornelia, Stering, Katharina, Hergan, Klaus, Mlineritsch, Brigitte, Greil, Richard
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357474/
https://ncbi.nlm.nih.gov/pubmed/30704493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-018-1091-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi